New data demonstrate the superiority of radial arterial access compared to femoral arterial access for coronary interventions.
Novartis to spend $200 million in further bid to boost radiopharma manufacturing, market dominance
Novartis is opening a new manufacturing facility in California and expanding an existing production site in its bid to dominate the booming radiopharmaceuticals field amid